Induced pluripotent stem cell technology: a decade of progress

Y Shi, H Inoue, JC Wu, S Yamanaka - Nature reviews Drug discovery, 2017 - nature.com
Since the advent of induced pluripotent stem cell (iPSC) technology a decade ago,
enormous progress has been made in stem cell biology and regenerative medicine. Human …

Induced pluripotent stem cells and their use in human models of disease and development

P Karagiannis, K Takahashi, M Saito… - Physiological …, 2019 - journals.physiology.org
The discovery of somatic cell nuclear transfer proved that somatic cells can carry the same
genetic code as the zygote, and that activating parts of this code are sufficient to reprogram …

Deep learning-based predictive identification of neural stem cell differentiation

Y Zhu, R Huang, Z Wu, S Song, L Cheng… - Nature communications, 2021 - nature.com
The differentiation of neural stem cells (NSCs) into neurons is proposed to be critical in
devising potential cell-based therapeutic strategies for central nervous system (CNS) …

Modeling sporadic Alzheimer's disease in human brain organoids under serum exposure

X Chen, G Sun, E Tian, M Zhang, H Davtyan… - Advanced …, 2021 - Wiley Online Library
Alzheimer's disease (AD) is a progressive neurodegenerative disease with no cure. Huge
efforts have been made to develop anti‐AD drugs in the past decades. However, all drug …

Genome-wide CRISPR activation screening in senescent cells reveals SOX5 as a driver and therapeutic target of rejuvenation

Y **g, X Jiang, Q Ji, Z Wu, W Wang, Z Liu… - Cell Stem Cell, 2023 - cell.com
Our understanding of the molecular basis for cellular senescence remains incomplete,
limiting the development of strategies to ameliorate age-related pathologies by preventing …

Self-organizing 3D human neural tissue derived from induced pluripotent stem cells recapitulate Alzheimer's disease phenotypes

WK Raja, AE Mungenast, YT Lin, T Ko, F Abdurrob… - PloS one, 2016 - journals.plos.org
The dismal success rate of clinical trials for Alzheimer's disease (AD) motivates us to
develop model systems of AD pathology that have higher predictive validity. The advent of …

[HTML][HTML] Autophagy and apoptosis dysfunction in neurodegenerative disorders

S Ghavami, S Shojaei, B Yeganeh, SR Ande… - Progress in …, 2014 - Elsevier
Autophagy and apoptosis are basic physiologic processes contributing to the maintenance
of cellular homeostasis. Autophagy encompasses pathways that target long-lived cytosolic …

Nuclear lamina erosion-induced resurrection of endogenous retroviruses underlies neuronal aging

H Zhang, J Li, Y Yu, J Ren, Q Liu, Z Bao, S Sun, X Liu… - Cell reports, 2023 - cell.com
The primate frontal lobe (FL) is sensitive to aging-related neurocognitive decline. However,
the aging-associated molecular mechanisms remain unclear. Here, using physiologically …

A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging

W Zhang, J Li, K Suzuki, J Qu, P Wang, J Zhou, X Liu… - Science, 2015 - science.org
Werner syndrome (WS) is a premature aging disorder caused by WRN protein deficiency.
Here, we report on the generation of a human WS model in human embryonic stem cells …

[HTML][HTML] Human iPSC-based modeling of late-onset disease via progerin-induced aging

JD Miller, YM Ganat, S Kishinevsky, RL Bowman, B Liu… - Cell stem cell, 2013 - cell.com
Reprogramming somatic cells to induced pluripotent stem cells (iPSCs) resets their identity
back to an embryonic age and, thus, presents a significant hurdle for modeling late-onset …